US Dollar vs MXN

Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

Regístrate

CGEN

Compugen (CGEN)

Compugen Ltd

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:CGEN

<< Anterior 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
05/03/2019	06:00	PR Newswire (US)	Compugen to Present at the Cowen and Company 39th Annual Health Care Conference	NASDAQ:CGEN	Compugen Ltd
01/03/2019	06:00	PR Newswire (US)	Compugen Presents Update on COM701 Phase 1 Trial at ASCO-SITC Clinical Immuno-Oncology Symposium	NASDAQ:CGEN	Compugen Ltd
26/02/2019	05:07	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NASDAQ:CGEN	Compugen Ltd
26/02/2019	01:00	PR Newswire (US)	Compugen Reports Fourth Quarter and Full Year 2018 Results and Announces Corporate Restructuring to Streamline Operations	NASDAQ:CGEN	Compugen Ltd
14/02/2019	10:35	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:CGEN	Compugen Ltd
14/02/2019	07:42	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:CGEN	Compugen Ltd
14/02/2019	06:00	PR Newswire (US)	Compugen Fourth Quarter and Full Year 2018 Conference Call Scheduled for Tuesday, February 26, 2019 at 8:30 AM ET	NASDAQ:CGEN	Compugen Ltd
22/01/2019	06:00	PR Newswire (US)	Compugen Announces Publication of Two Peer-Reviewed Papers Demonstrating the Role of PVRIG as a Novel Immune Checkpoint for C...	NASDAQ:CGEN	Compugen Ltd
14/01/2019	06:00	PR Newswire (US)	Compugen's Phase 1 Trial of COM701 Featured as a Trial-in-Progress at The ASCO-SITC Clinical Immuno-Oncology Symposium	NASDAQ:CGEN	Compugen Ltd
04/12/2018	15:28	Edgar (US Regulatory)	Confidential Treatment Order (ct Order)	NASDAQ:CGEN	Compugen Ltd
13/11/2018	06:00	PR Newswire (US)	Compugen Announces Issuance of U.S. Patent for COM902, Its TIGIT Antibody Product Candidate for Cancer Immunotherapy	NASDAQ:CGEN	Compugen Ltd
07/11/2018	06:00	PR Newswire (US)	Compugen Reports Third Quarter 2018 Results	NASDAQ:CGEN	Compugen Ltd
24/10/2018	06:15	PR Newswire (US)	Compugen Third Quarter 2018 Conference Call Scheduled for Wednesday, November 7, 2018 at 8:30 AM ET	NASDAQ:CGEN	Compugen Ltd
16/10/2018	10:04	Edgar (US Regulatory)	Small Company Offering and Sale of Securities Without Registration (d)	NASDAQ:CGEN	Compugen Ltd
11/10/2018	06:50	Dow Jones News	Bristol-Myers, Compugen to Collaborate on Advanced Solid Tumors	NASDAQ:CGEN	Compugen Ltd
11/10/2018	05:59	PR Newswire (US)	Bristol-Myers Squibb and Compugen Announce Clinical Collaboration to Evaluate Therapeutic Regimen in Advanced Solid Tumors	NASDAQ:CGEN	Compugen Ltd
20/09/2018	06:00	PR Newswire (US)	Compugen Announces Clinical Milestone Payment in Cancer Immunotherapy Collaboration With Bayer Following Dosing of First Pati...	NASDAQ:CGEN	Compugen Ltd
07/09/2018	06:00	PR Newswire (US)	Compugen Announces First Patient Dosed with COM701, a First-in-Class Cancer Immunotherapy Antibody, in Phase 1 Clinical Trial	NASDAQ:CGEN	Compugen Ltd
05/09/2018	06:00	PR Newswire (US)	Compugen Announces Appointment of Dr. Jean-Pierre Bizzari to its Board of Directors	NASDAQ:CGEN	Compugen Ltd
01/08/2018	06:00	PR Newswire (US)	Compugen Reports Second Quarter 2018 Results	NASDAQ:CGEN	Compugen Ltd
18/07/2018	06:00	PR Newswire (US)	Compugen Second Quarter 2018 Conference Call Scheduled for Wednesday, August 1, 2018 at 8:30 AM ET	NASDAQ:CGEN	Compugen Ltd
02/07/2018	06:05	PR Newswire (US)	Compugen Welcomes FDA Clearance of Bayer's IND Application for BAY 1905254	NASDAQ:CGEN	Compugen Ltd
02/07/2018	06:00	PR Newswire (US)	Compugen Announces FDA Clearance of IND Application for COM701, a First-in-class Immuno-Oncology Therapeutic Antibody	NASDAQ:CGEN	Compugen Ltd
18/06/2018	13:56	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:CGEN	Compugen Ltd
15/06/2018	06:00	PR Newswire (US)	Compugen Announces $21 Million Registered Direct Offering of Ordinary Shares and Warrants	NASDAQ:CGEN	Compugen Ltd
11/06/2018	06:00	PR Newswire (US)	Compugen Announces the Appointment of New Board Members	NASDAQ:CGEN	Compugen Ltd
09/05/2018	06:00	PR Newswire (US)	Compugen Reports First Quarter 2018 Results	NASDAQ:CGEN	Compugen Ltd
30/04/2018	06:00	PR Newswire (US)	Compugen First Quarter 2018 Conference Call Scheduled for Wednesday, May 9, 2018 at 10:00 AM ET	NASDAQ:CGEN	Compugen Ltd
27/04/2018	07:52	PR Newswire (US)	Compugen Reports on Status of Investigational New Drug Application for COM701, a First-in-Class Immuno-Oncology Therapeutic A...	NASDAQ:CGEN	Compugen Ltd
17/04/2018	06:00	PR Newswire (US)	Preclinical Data Presented by Bayer at AACR Highlights BAY 1905254, Formerly the CGEN-15001T Program, Efficacy in Cancer Immu...	NASDAQ:CGEN	Compugen Ltd

Showing the most relevant articles for your search:NASDAQ:CGEN

<< Anterior 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Próxima >

Euro vs US Dollar

BNP Paribas (QX)

Deutsche Telekom (QX)

Verizon Communications

Financial Select Sector

Health Care Select Sector

US Dollar vs MXN

Delayed Upgrade Clock

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones